Mangoceuticals (MGRX) Non-Current Debt (2022 - 2026)
Mangoceuticals (MGRX) posted Non-Current Debt of $78260.0 for Q4 2022.
Mangoceuticals (MGRX) Non-Current Debt (2022 - 2026) Analysis & Trends
Mangoceuticals has reported Non-Current Debt for 1 years, with the latest figure at $78260.0 in Q4 2022.
- Quarterly Non-Current Debt changed N/A year-over-year to $78260.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $78260.0 (changed N/A YoY) and the FY2022 annual result came in at $78260.0, changed N/A from the prior year.
- Non-Current Debt held at $78260.0 in Q4 2022 per MGRX's latest filing.
- Over five years, Non-Current Debt peaked at $78260.0 in Q4 2022 and troughed at $78260.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 2.15 Bn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 942.66 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | - |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 1.45 Bn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | - |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Mangoceuticals | 9.55 Mn | 9.30 Mn | 44,215.00 | 44,944.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44,944.00 |
| Dec 31, 2022 | 78,260.00 |